Literature DB >> 27630642

Corrigendum: Recent Advances in Lentiviral Vaccines for HIV-1 Infection.

Abstract

[This corrects the article on p. 243 in vol. 7, PMID: 27446074.].

Entities: Disease

Keywords: HIV-1; HIV-1 vaccines; SAMHD1; Vpx; dendritic cells; lentiviral vectors

Year: 2016 PMID： 27630642 PMCID： PMC5021684 DOI： 10.3389/fimmu.2016.00354

Source DB: PubMed Journal: Front Immunol ISSN： 1664-3224 Impact factor: 7.561

In the original article, an error in the references in the section entitled “Addressing Safety Concerns with LV Vaccine Vectors” is present. Reference number 20 which is cited twice in this section is an error and should instead be Di Nunzio et al. (1). The authors apologize for this. This error does not change the scientific conclusions of the article in any way.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

1 in total

Review 1. HIV-derived vectors for therapy and vaccination against HIV.

Authors: F Di Nunzio; T Félix; N J Arhel; S Nisole; P Charneau; A-S Beignon
Journal: Vaccine Date: 2012-02-13 Impact factor: 3.641

1 in total

1. Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15_II in Murine Model.

Authors: Lei Liu; Mengmeng Jin; Qing Tao; Li Yu; Jian Du; Cong Wang; Qingli Luo; Tian Xing; Yuanhong Xu; Jilong Shen; Deyong Chu
Journal: Front Immunol Date: 2018-07-06 Impact factor: 7.561

1 in total

Corrigendum: Recent Advances in Lentiviral Vaccines for HIV-1 Infection.

Conflict of Interest Statement

Review 1. HIV-derived vectors for therapy and vaccination against HIV.

1. Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15II in Murine Model.

1. Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15_II in Murine Model.